These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15994388)

  • 21. Predictors of COPD symptoms: does the sex of the patient matter?
    Watson L; Schouten JP; Löfdahl CG; Pride NB; Laitinen LA; Postma DS;
    Eur Respir J; 2006 Aug; 28(2):311-8. PubMed ID: 16707516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of acute bronchodilator tests in patients with chronic obstructive lung disease and bronchial asthma].
    Vizel' AA; Vizel' IIu; Vizel' EA
    Probl Tuberk Bolezn Legk; 2005; (7):40-4. PubMed ID: 16130428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchial obstruction reversibility test in the assessment of COPD severity--controversies].
    Maskey-Warzechowska M; Pankowska M; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):68-71. PubMed ID: 17175980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-bronchodilator spirometry reference values in adults and implications for disease management.
    Johannessen A; Lehmann S; Omenaas ER; Eide GE; Bakke PS; Gulsvik A
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1316-25. PubMed ID: 16556696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm.
    Sposato B; Mariotta S; Ricci A; Bruno P; Terzano C; Mannino F
    Eur Rev Med Pharmacol Sci; 2005; 9(2):117-23. PubMed ID: 15945501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations.
    Calverley PM; Albert P; Walker PP
    Lancet Respir Med; 2013 Sep; 1(7):564-73. PubMed ID: 24461617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the protective effect amongst anticholinergic drugs on methacholine-induced bronchoconstriction in asthma.
    Sposato B; Barzan R; Calabrese A; Franco C
    J Asthma; 2008 Jun; 45(5):397-401. PubMed ID: 18569233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study.
    Wise RA; Enright PL; Connett JE; Anthonisen NR; Kanner RE; Lindgren P; O'Hara P; Owens GR; Rand CS; Tashkin DP
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):866-72. PubMed ID: 9517604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.
    Tashkin DP; Altose MD; Connett JE; Kanner RE; Lee WW; Wise RA
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1802-11. PubMed ID: 8665038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A three years longitudinal follow-up study of pulmonary function changes in patients with chronic obstructive pulmonary disease].
    Wang J; Zhou XM; Yang X; Zhao ST; Ma QL; Wang CZ
    Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):302-6. PubMed ID: 27030620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In long-term smokers and former smokers the bronchodilator response is not related to the fall in FEV.
    Stănescu D; Veriter C; Sanna A
    Respiration; 1999; 66(6):501-5. PubMed ID: 10575334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchodilator reversibility in COPD: the roguish but harmless little brother of airway hyperresponsiveness?
    Hansen EF; Vestbo J
    Eur Respir J; 2005 Jul; 26(1):6-7. PubMed ID: 15994382
    [No Abstract]   [Full Text] [Related]  

  • 34. Bronchodilator reversibility testing in chronic obstructive pulmonary disease.
    Calverley PM; Burge PS; Spencer S; Anderson JA; Jones PW
    Thorax; 2003 Aug; 58(8):659-64. PubMed ID: 12885978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung function decline in asthma.
    Sears MR
    Eur Respir J; 2007 Sep; 30(3):411-3. PubMed ID: 17766631
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study.
    Wise RA; Kanner RE; Lindgren P; Connett JE; Altose MD; Enright PL; Tashkin DP;
    Chest; 2003 Aug; 124(2):449-58. PubMed ID: 12907528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease.
    Harber P; Tashkin DP; Simmons M; Crawford L; Hnizdo E; Connett J;
    Am J Respir Crit Care Med; 2007 Nov; 176(10):994-1000. PubMed ID: 17626912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in smoking status affect women more than men: results of the Lung Health Study.
    Connett JE; Murray RP; Buist AS; Wise RA; Bailey WC; Lindgren PG; Owens GR;
    Am J Epidemiol; 2003 Jun; 157(11):973-9. PubMed ID: 12777360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of correlation between bronchoconstrictor response and bronchodilator response in a population-based study.
    Douma WR; de Gooijer A; Rijcken B; Schouten JP; Koëter GH; Weiss ST; Postma DS
    Eur Respir J; 1997 Dec; 10(12):2772-7. PubMed ID: 9493659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD.
    Lee DK
    Eur Respir J; 2004 Aug; 24(2):332; author reply 332-3. PubMed ID: 15332409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.